These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37365024)

  • 1. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B].
    Wang XH; Liu XQ; Cai DC; Hu P; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
    Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.
    Wei S; Xie Q; Liao G; Chen H; Hu M; Lin X; Li H; Peng J
    BMC Gastroenterol; 2024 Mar; 24(1):120. PubMed ID: 38532310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
    Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
    Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
    Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
    Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
    Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of hepatic pathological inflammation and fibrosis condition and its influencing factors in 721 patients with chronic hepatitis B with normal ALT].
    Ning HB; Jin HM; Li K; Peng Z; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):746-751. PubMed ID: 36038345
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the predictive value of plateletcrit for the degree of liver fibrosis in patients with chronic HBV infection with ALT less than two times the upper limit of normal].
    Wang B; Li Y; Xiao L; Xu HT; Xian JC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):862-868. PubMed ID: 37723069
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
    Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
    Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of FibroScan in liver fibrosis evaluation in patients with chronic hepatitis B virus infection and related influencing factors].
    Xie QX; Xu N; Jiang XP; Zhang YF; Zhang ZH; Li JB; Hu XY; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):659-664. PubMed ID: 27788721
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver histology of treatment-naïve children with chronic hepatitis B virus infection in Shanghai China.
    Hu Y; Wu X; Ye Y; Ye L; Han S; Wang X; Yu H
    Int J Infect Dis; 2022 Oct; 123():112-118. PubMed ID: 36028208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN].
    Xian JC; Xu HT; He YL; Shen ML; Chen YB; Zhang LX; Xiao L; Li Y; Han LB; Li H; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):431-5. PubMed ID: 22053373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
    Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
    Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with meta-analysis: Significant histological changes among treatment-naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria.
    Li S; Shi L; Xu X; Wang H; You H; Jia J; Kong Y
    Aliment Pharmacol Ther; 2023 Oct; 58(7):648-658. PubMed ID: 37551720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.
    Deng YQ; Zhao H; Ma AL; Zhou JY; Xie SB; Zhang XQ; Zhang DZ; Xie Q; Zhang G; Shang J; Cheng J; Zhao WF; Zou ZQ; Zhang MX; Wang GQ;
    Medicine (Baltimore); 2015 Nov; 94(45):e2003. PubMed ID: 26559292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.